Alnylam Pharmaceuticals
ALNY
#854
Rank
C$41.94 B
Marketcap
C$313.46
Share price
0.32%
Change (1 day)
-46.98%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company